List of works - Beshay N Zordoky

3-methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats

scientific article

AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism

scientific article

Acute arsenic treatment alters cytochrome P450 expression and arachidonic acid metabolism in lung, liver and kidney of C57Bl/6 mice

scientific article published on 15 February 2013

Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver.

scientific article

Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.

scientific article published on 13 December 2017

Cardiomyocyte specific adipose triglyceride lipase overexpression prevents doxorubicin induced cardiac dysfunction in female mice.

scientific article published on 23 May 2013

Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats.

scientific article published on 6 August 2012

Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity

article

Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.

scientific article

Determination of the dominant arachidonic acid cytochrome p450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics.

scientific article published on 10 November 2012

Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice.

scientific article published on 16 August 2012

EA.hy926 Cells and HUVECs Share Similar Senescence Phenotypes but Respond Differently to the Senolytic Drug ABT-263

scientific article published in 2022

Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases

scientific article

Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells.

scientific article

Lack of sexual dimorphism in a mouse model of isoproterenol-induced cardiac dysfunction

scientific article published on 09 July 2020

Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology

scientific article published on 14 March 2019

Metabolomic fingerprint of heart failure with preserved ejection fraction

scientific article published on 26 May 2015

Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure.

scientific article published on February 2008

Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats.

scientific article published on 25 August 2008

Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.

scientific article

Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.

scientific article published on 22 May 2013

Role of NF-kappaB in the regulation of cytochrome P450 enzymes.

scientific article published on February 2009

Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.

scientific article published on May 2013

Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice

scientific article published on 07 January 2017

Sexual Dimorphism in Doxorubicin-induced Systemic Inflammation: Implications for Hepatic Cytochrome P450 Regulation

scientific article published on 14 February 2020

Sexual dimorphism of acute doxorubicin-induced nephrotoxicity in C57Bl/6 mice

scientific article published on 20 February 2019

Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.

scientific article published on April 2013

The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.

scientific article published on 23 January 2014

The interplay between genetic background and sexual dimorphism of doxorubicin-induced cardiotoxicity.

scientific article published on 15 March 2016

List of works by Beshay N Zordoky

3-methylcholanthrene and benzo(a)pyrene modulate cardiac cytochrome P450 gene expression and arachidonic acid metabolism in male Sprague Dawley rats

AMPK deficiency in cardiac muscle results in dilated cardiomyopathy in the absence of changes in energy metabolism

Acute arsenic treatment alters cytochrome P450 expression and arachidonic acid metabolism in lung, liver and kidney of C57Bl/6 mice

Acute doxorubicin toxicity differentially alters cytochrome P450 expression and arachidonic acid metabolism in rat kidney and liver.

Anticancer effects of resveratrol in canine hemangiosarcoma cell lines.

Cardiomyocyte specific adipose triglyceride lipase overexpression prevents doxorubicin induced cardiac dysfunction in female mice.

Chronic doxorubicin cardiotoxicity modulates cardiac cytochrome P450-mediated arachidonic acid metabolism in rats.

Clinical and preclinical evidence of sex-related differences in anthracycline-induced cardiotoxicity

Co-administration of resveratrol with doxorubicin in young mice attenuates detrimental late-occurring cardiovascular changes.

Determination of the dominant arachidonic acid cytochrome p450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics.

Differential effects of soluble epoxide hydrolase inhibition and CYP2J2 overexpression on postischemic cardiac function in aged mice.

EA.hy926 Cells and HUVECs Share Similar Senescence Phenotypes but Respond Differently to the Senolytic Drug ABT-263

Effect of cytochrome P450 polymorphism on arachidonic acid metabolism and their impact on cardiovascular diseases

Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells.

Lack of sexual dimorphism in a mouse model of isoproterenol-induced cardiac dysfunction

Leveraging the Cardio-Protective and Anticancer Properties of Resveratrol in Cardio-Oncology

Metabolomic fingerprint of heart failure with preserved ejection fraction

Modulation of cardiac and hepatic cytochrome P450 enzymes during heart failure.

Modulation of cytochrome P450 gene expression and arachidonic acid metabolism during isoproterenol-induced cardiac hypertrophy in rats.

Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.

Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice.

Role of NF-kappaB in the regulation of cytochrome P450 enzymes.

Role of cytochrome P450-mediated arachidonic acid metabolites in the pathogenesis of cardiac hypertrophy.

Sex-dependent alteration of cardiac cytochrome P450 gene expression by doxorubicin in C57Bl/6 mice

Sexual Dimorphism in Doxorubicin-induced Systemic Inflammation: Implications for Hepatic Cytochrome P450 Regulation

Sexual dimorphism of acute doxorubicin-induced nephrotoxicity in C57Bl/6 mice

Soluble epoxide hydrolase inhibitor, TUPS, protects against isoprenaline-induced cardiac hypertrophy.

The anti-proliferative effect of metformin in triple-negative MDA-MB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention.

The interplay between genetic background and sexual dimorphism of doxorubicin-induced cardiotoxicity.